Peter E. Schwartz

8.0k total citations
166 papers, 5.6k citations indexed

About

Peter E. Schwartz is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Peter E. Schwartz has authored 166 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Obstetrics and Gynecology, 86 papers in Reproductive Medicine and 43 papers in Surgery. Recurrent topics in Peter E. Schwartz's work include Endometrial and Cervical Cancer Treatments (80 papers), Ovarian cancer diagnosis and treatment (78 papers) and Uterine Myomas and Treatments (44 papers). Peter E. Schwartz is often cited by papers focused on Endometrial and Cervical Cancer Treatments (80 papers), Ovarian cancer diagnosis and treatment (78 papers) and Uterine Myomas and Treatments (44 papers). Peter E. Schwartz collaborates with scholars based in United States, Italy and China. Peter E. Schwartz's co-authors include Ernest I. Kohorn, Joseph T. Chambers, Thomas Rutherford, Setsuko K. Chambers, Beth E. Nelson, Arthur T. Rosenfield, Wenxin Zheng, Gil Mor, Pei Hui and Michael Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Peter E. Schwartz

162 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Schwartz United States 41 2.7k 2.6k 1.0k 998 814 166 5.6k
John T. Soper United States 51 3.6k 1.3× 3.5k 1.4× 1.9k 1.9× 1.5k 1.5× 1.3k 1.6× 191 8.3k
Sean Kehoe United Kingdom 35 2.4k 0.9× 3.0k 1.2× 1.4k 1.3× 1.9k 1.9× 721 0.9× 146 5.8k
Paola A. Gehrig United States 49 4.0k 1.4× 3.0k 1.2× 1.7k 1.6× 1.3k 1.3× 1.7k 2.1× 221 7.5k
Linda Duska United States 35 1.9k 0.7× 2.1k 0.8× 1.2k 1.2× 845 0.8× 679 0.8× 232 4.4k
Ginger J. Gardner United States 44 2.6k 1.0× 3.3k 1.3× 1.2k 1.1× 2.0k 2.0× 839 1.0× 193 5.7k
Roberto Angioli Italy 42 3.0k 1.1× 2.8k 1.1× 1.1k 1.1× 2.3k 2.3× 654 0.8× 286 6.3k
Brian M. Slomovitz United States 34 2.5k 0.9× 2.1k 0.8× 1.4k 1.4× 632 0.6× 1.1k 1.3× 219 5.2k
Angeles Alvarez Secord United States 46 3.0k 1.1× 3.6k 1.4× 2.3k 2.2× 1.1k 1.1× 1.5k 1.8× 288 7.2k
J.T. Thigpen United States 36 4.9k 1.8× 3.6k 1.4× 2.1k 2.1× 2.5k 2.5× 1.1k 1.3× 175 8.5k
Ritu Salani United States 36 1.8k 0.7× 2.3k 0.9× 1.3k 1.3× 1.3k 1.3× 661 0.8× 165 4.6k

Countries citing papers authored by Peter E. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Peter E. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Schwartz more than expected).

Fields of papers citing papers by Peter E. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Schwartz. The network helps show where Peter E. Schwartz may publish in the future.

Co-authorship network of co-authors of Peter E. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Schwartz. A scholar is included among the top collaborators of Peter E. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Schwartz. Peter E. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
AlAshqar, Abdelrahman, Emily Webster, Masoud Azodi, et al.. (2023). Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities. Gynecologic Oncology Reports. 49. 101240–101240. 2 indexed citations
2.
Xu, Xiao, Vrunda B. Desai, Peter E. Schwartz, et al.. (2022). Safety Warning about Laparoscopic Power Morcellation in Hysterectomy: A Cost-Effectiveness Analysis of National Impact. Women s Health Reports. 3(1). 369–384. 2 indexed citations
3.
Webster, Emily, et al.. (2021). An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva. Journal of Gynecologic Oncology. 33(2). e13–e13. 10 indexed citations
4.
Young, Melissa R., Gloria S. Huang, Babak Litkouhi, et al.. (2020). Stage III uterine serous carcinoma: modern trends in multimodality treatment. Journal of Gynecologic Oncology. 31(4). e53–e53.
5.
Albright, Benjamin B., Jonathan D. Black, Stefan Gysler, et al.. (2018). Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecologic Oncology Reports. 23. 28–33. 3 indexed citations
6.
Roque, Dana M., et al.. (2014). Appearances can be deceiving. American Journal of Obstetrics and Gynecology. 211(3). 310.e1–310.e2. 3 indexed citations
7.
Schwartz, Peter E., Pei Hui, & Shirley McCarthy. (2014). Hormonal Therapy for Aggressive Angiomyxoma. Journal of Lower Genital Tract Disease. 18(2). E55–E61. 18 indexed citations
8.
Zhang, Xi, Sharon X. Liang, Lin Jia, et al.. (2009). Molecular Identification of “Latent Precancers” for Endometrial Serous Carcinoma in Benign-Appearing Endometrium. American Journal Of Pathology. 174(6). 2000–2006. 23 indexed citations
9.
Cornfeld, Daniel, Gary M. Israel, Maritza Martel, et al.. (2009). MRI appearance of mesenchymal tumors of the uterus. European Journal of Radiology. 74(1). 241–249. 55 indexed citations
10.
Schwartz, Peter E.. (2006). The management of serous papillary uterine cancer. Current Opinion in Oncology. 18(5). 494–499. 39 indexed citations
11.
Mor, Gil, Irene Visintin, Yinglei Lai, et al.. (2005). Serum protein markers for early detection of ovarian cancer. Proceedings of the National Academy of Sciences. 102(21). 7677–7682. 357 indexed citations
12.
Zheng, Wenxin, Sharon X. Liang, Herbert Yu, et al.. (2004). Endometrial Glandular Dysplasia: A Newly Defined Precursor Lesion of Uterine Papillary Serous Carcinoma. Part I: Morphologic Features. International Journal of Surgical Pathology. 12(3). 207–223. 59 indexed citations
13.
Ezzat, Adnan, et al.. (1999). Malignant Ovarian Germ Cell Tumours: A Survival and Prognostic Analysis. Acta Oncologica. 38(4). 455–460. 18 indexed citations
14.
Turner, Bruce, Jonathan Knisely, Barry M. Kacinski, et al.. (1998). Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 40(1). 77–84. 64 indexed citations
15.
Fishman, David A., Kenneth B. Roberts, Joseph T. Chambers, et al.. (1996). Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the Endometrium. Gynecologic Oncology. 61(2). 189–196. 52 indexed citations
16.
WALKER, R. P., et al.. (1995). Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.. PubMed. 14(5A). 1703–9. 4 indexed citations
17.
Chambers, Setsuko K., Lynne Lamb, Ernest I. Kohorn, Peter E. Schwartz, & Joseph T. Chambers. (1994). Chemotherapy of Recurrent/Advanced Cervical Cancer: Results of the Yale University PBM-PFU Protocol. Gynecologic Oncology. 53(2). 161–169. 9 indexed citations
18.
Kacinski, Barry M., Darryl Carter, Khushbakhat Mittal, et al.. (1988). High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. International Journal of Radiation Oncology*Biology*Physics. 15(4). 823–829. 71 indexed citations
19.
Chambers, Setsuko K., Joseph T. Chambers, Ernest I. Kohorn, & Peter E. Schwartz. (1987). Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancer. Gynecologic Oncology. 27(2). 233–240. 13 indexed citations
20.
LiVolsi, Virginia A., Theodore R. Holford, Diana Fischer, et al.. (1982). A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM. American Journal of Epidemiology. 116(2). 333–342. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John T. Soper Breakdown of academic impact, for papers by Sean Kehoe Breakdown of academic impact, for papers by Paola A. Gehrig Breakdown of academic impact, for papers by Linda Duska Breakdown of academic impact, for papers by Ginger J. Gardner Breakdown of academic impact, for papers by Roberto Angioli Breakdown of academic impact, for papers by Brian M. Slomovitz Breakdown of academic impact, for papers by Angeles Alvarez Secord Breakdown of academic impact, for papers by J.T. Thigpen Breakdown of academic impact, for papers by Ritu Salani
Rankless by CCL
2026